As the only in-person platform dedicated exclusively to analytical development for CRISPR-based therapies, this event offers a unique opportunity to position your brand in front of an engaged, technically focused, and hyper-relevant audience in the genome editing space.
With increasing demand for regulatory-ready analytics, off-target detection, and potency assay development, analytical teams are actively seeking expert partners to support their CRISPR programs from discovery through to GMP readiness.
Whether you offer sequencing platforms, assay development services, or regulatory consulting, this is your chance to showcase your solutions to the decision-makers shaping the future of gene editing.
❝
The attendee list was wonderful, and it was great to network with experts in the gene editing field.
President & Chief Scientific Officer, SeQure Dx
2024 Partner
Current Partner:
Our Audience are Looking to Work With:
Instrument Providers:
Showcase cutting-edge analytical instruments designed for CRISPR workflows, from high-resolution sequencing systems to delivery characterization tools that support precision genome editing.
Sequencing Companies:
Present your NGS, long-read, and hybrid capture platforms that enable high-fidelity off-target detection, structural variant analysis, and product integrity validation.
Assay Providers & CROs:
Offer validated assays and outsourced analytical services to help biotech and pharma teams accelerate method development, validation, and regulatory readiness with confidence.
Bioassay Software & Data Analytics Platforms:
Provide tools that help analytical teams interpret complex datasets, automate workflows, and ensure reproducibility across CRISPR assay development.
Why Partner?
Brand Exposure
Position your brand prominently and showcase your solutions to an audience actively seeking analytical, sequencing, and assay development support for CRISPR-based therapies.
Thought Leadership
Demonstrate your expertise in genome editing analytics, from cell line development and guide RNA validation to GMP-grade manufacturing, alongside leading voices in the field.
Networking Opportunities
Engage directly with heads of AD, directors, and technical experts responsible for analytical development, QC, and regulatory strategy–unlocking high-value partnerships and commercial opportunities.
Harness Market Intelligence
Analytical teams are engaging with service providers more than ever, so make sure your offerings are reflective of their changing needs and priorities.
Who Will You Meet?
Explore Other Related Events
The Gene Therapy Event Series spans in-depth content for each role and specification in gene therapy drug development, so you can curate your event calendar to meet industry leaders most relevant to your area of expertise across the year. Download our Partnership Prospectus now to find out more.
